Parasitological, pathological and immunological effects of hesperidin treatment on murine schistosomiasis mansoni

Life Science Journal

Volumn 11, Issue 7, 2014, Pages 840-855

  El Aswad, Bahaa El Deen W ^a   Sadek, Gehan S ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Cytokines; Hesperidin; S.mansoni

Indexed keywords

EID: 84904504512     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (112)

1. Allam G. (2009): Immuno modulatory effects of curcumin treatment on murine schistosomiasis mansoni. Immunobiol, 214: 712-27.
2. Allam G. and Abuelsaad A. S. A. (2013a): In vitroand in vivo effects of hesperidin treatment on adult worms of Schistosoma mansoni. J Helminthol, 9: 1-9.
3. Allam G. and Abuelsaad A. S. A. (2013b):Differential effect of hesperidin on Th1, Th2, Th17, and proinflammatory cytokines production from splenocyte of Schistosoma mansoni-infected mice. Cent Eur J Immunol, 38: 29-36
4. Aly I. R., Hendawy M. A., Ali E., Hassan E. and Nosseir M. M. (2010): Immunological and parasitological parameters after treatment with dexamethasone in murine Schistosoma mansoni. Mem Inst Oswaldo Cruz, 105(6): 729-35
5. Amiri P., Locksley R. M., Parslow T. G., Sadick M., Rector E., Ritter D. and McKerrow J. H. (1992): Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosomeinfected SCID mice. Nature, 356: 604-7
6. Anderson S., Shires V. L., Wilson R. A. and Mountford A. P. (1998): In the absence of IL-12, the induction of Th1-mediated protective immunity by the attenuated schistosome vaccine is impaired, revealing an alternative pathway with Th2-type characteristics. Eur J Immunol, 28: 2827-38
7. Aragona A. D., Imania R. A., Blackburn V. R., Cupit P. M., Melman S. D, Goronga T., Webb T., Loker E. S. and Cunningham C. (2009):Towards an understanding of the mechanism of action of praziquantel. Mol Biochem Parasitol, 164(1): 57-65
8. Asadullah K., Sterry W. and Volk H.D. (2003): Interleukin-10 therapy-review of a new approach. Pharmacol Rev, 55: 241-69
9. Bae E. A., Han M. J. and Kim D. H. (1999): In vitro anti-Helicobacter activity of some flavonoids and their metabolites. Planta Med, 65: 442-3
10. Barthe G. A., Jourdan P. S., McIntosh C. A. and Mansell R. L. (1988): Radioimmunoassay for the quantitative determination of hesperidin and analysis of its distribution in Citrus sinensis. Phytochem, 27: 249-54
11. Beckmann S., Leutner S., Gouignard N., Dissous C. and Grevelding C. G. (2012): Protein kinases as potential targets for novel anti-schistosomal strategies. Curr Pharm Des, 18: 3579-94
12. Bergquist NR (2002): Schistosomiasis: from risk assessment to control. Trends Parasitol, 18: 309-14
13. Bergquist R., Al-Sherbiny M., Barakat R. and Olds R. (2002): Blueprint for schistosomiasis vaccine development. Acta Trop, 82: 183-92
14. Boisseau M. R. (2002): Pharmacological targets of drugs employed in chronic venous and lymphatic insufficiency. Intern Angiol, 21: 33-9
15. Botros S. S. and Bennett J.L. (2007): Praziquantel resistance. Expert Opin Drug Discov, 2 (s1): S35-40
16. Botros S., William S., Ebeid F., Cioli D., Katz N., Day T. and Bennett J. (2004):Lack of evidence for an antischistosomal activity of myrrh in experimental animals. Am J Trop Med Hyg, 71: 206-10
17. Brindley P. J. and Sher A. (1987): The chemotherapeutic effect of praziquantel against Schistosoma mansoniis dependent on host antibody response. J Immunol, 139: 215-20
18. Caffrey C. R. (2007):Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol, 11: 433-9
19. Capron M. and Capron A. (1994): Immunoglobulin E and effector cells in schistosomiasis. Science, 264: 1876-7
20. Chen F. L., Yang Z. H., Liu Y., Li L. X., Liang W. C., Wang X. C., Zhou W. B., Yang Y. H. and Hu R. M. (2008): Berberine inhibits the expression of TNF alpha, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPAR gamma pathway. Endocrine, 33(3): 331-7
21. Chen M., Gu H., Ye Y., Lin B., Sun L., Deng W., Zhang J. and Liu J. (2010):Protective effects of hesperidin against oxidative stress of tert-butyl hydroperoxide in human hepatocytes. Food Chem Toxicol, 48: 2980-7
22. Chitsulo L., Loverde P. and Engels D. (2004): Schistosomiasis. Nat Rev Microbiol, 2: 12-13
23. Coura J. R. and Amaral R. S. (2004): Epidemiological and control aspects of schistosomiasis in Brazilian endemic areas. Mem Inst Oswaldo Cruz, 99 (Suppl. I): 13-19
24. Croft S. L., Vivas L. and Brooker S. (2003): Recent advances in research and control of malaria, leishmaniasis, trypanosomiasis and schistosomiasis. East Mediterr Health J, 9: 518-33.
25. das Neves R. N., Carvalho F., Carvalho M., Fernandes E., Soares E., Bastos M. D. and Pereira M. D. (2004): Protective activity of hesperidin and lipoic acid against sodium arsenite acute toxicity in mice. Toxicol Pathol, 32: 527-35.
26. Davies E., Tsang C. W., Ghazali A. R., Harris R. M. and Waring R. H. (2004): Effects of culture with TNF-alpha, TGF-beta and insulin on sulphotransferase (SULT 1A1 and 1A3) activity in human colon and neuronal cell lines. Toxicol In Vitro, 18(6): 749-54
27. de Moraes J., de Oliveira R. N., Costa J. P., Junior A. L., de Sousa D. P., Freitas R. M., Allegretti S. M. and Pinto P. L. (2014): Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease Schistosomiasis mansoni. PLoS Negl Trop Dis, 8(1): e2617.
28. Doenhoff M. J., Cioli D. and Utzinger J. (2008): Praziquantel:mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis, 21: 659-67
29. Doenhoff M. J., Sabah A. A., Fletcher C., Webbe G. and Bain J. (1987): Evidence for an immunedependent action of praziquantel on Schistosoma mansoni in mice. Trans R Soc Trop Med Hyg, 81: 947-51
30. Dunne D. and Mountford A. (2001): Resistance to infection in humans and animal models. pp. 133-212 in Mahmoud, A.A.F. (Ed.) Schistosomiasis. London, UK, Imperial College Press
31. El Ridi R. (2002): Toward a complete immunityinducing vaccine for schistosomiasis. J Parasitol, 88: 1049-50
32. El-Lakkany N. M. and el-Din S. H. S. (2013):Haemin enhances the in vivoefficacy of artemether against juvenile and adult Schistosoma mansoni in mice. Parasitol Res, 112: 2005-15
33. Engvall E. and Perlmann P. (1971): Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochem, 8: 871-74
34. Fallon P. G. and Doenhoff M. J. (1994): Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg, 51: 83-8
35. Fallon P. G. and Dunne D. W. (1999):Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection. J Immunol, 162 (7): 4122-32
36. Fallon P. G., Richardson E. J., McKenzie G. J. and McKenzie A. N. J. (2000): Schistosoma infection of transgenic mice defines distinct and contradictory pathogenic roles of IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol, 164: 2585-91
37. Fenwick A., Savioli L., Engels D., Bergquist N.R. and Todd M. H. (2003): Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol, 19: 509-15
38. Flisser A. and McLaren D. J. (1989): Effect of praziquantel treatment on lung stage larvae of Schistosoma mansoni in vivo. Parasitol, 2: 203-11
39. Flores-Villanueva P. O., Zheng X. X., Strom T. B. and Stadecker M. J. (1996):Recombinant IL-10 and IL-10/Fc treatment down regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J. Immunol, 156:3315-20
40. Fonseca C. T., Brito C. F., Alves J. B. and Oliveria S. C. (2004): IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-α dependent pathway. Vaccine, 2: 503-10
41. Galati E. M., Monforte M. T., Kirjavainen S., Forestieri A. M., Trovato A. and Tripodo M. M. (1994): Biological effects of hesperidin, a citrus flavonoid. (Note I): antiinflammatory and analgesic activity. Farmaco, 40(11): 709-12
42. Grzych J., Grezel D., Xu C. B., Neyrinck J., Capron M., Ouma J., Butterworth A. and Capron A. (1993): IgA antibodies to a protective antigen in human schistosomiasis mansoni. J Immunol, 150: 527-35
43. Haseeb M. A., Shirazian D. J. and Preis J. (2001): Elevated serum levels of TNF-alpha, sTNF-RI and sTNF-RII in murine schistosomiasis correlate with schistosome oviposition and circumoval granuloma formation. Cytokine, 15(5): 266-9.
44. Hernandez H. J., Wang Y., Tzellas N. and Stadecker M. J. (1997):Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with Schistosoma mansoni. Eur J Immunol, 27: 1170-6.
45. Hesse M., Piccirillo C. A., Belkaid Y., Prufer J., Mentink-Kane M., Leusink M., Cheever A. W., Shevach E. M. and Wynn T. A. (2004): The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol, 172: 3157-66.
46. Hirano T. (1994): Interleukin-6. In: The Cytokine Handbook, (ed. A. W. Thomson), pp. 186, Harcourt Brace& Company, Publishers, Academic Press, London, San Diego, New York, Boston, Sydney, Tokyo and Toronto.
47. Hoffmann K. F., Caspar P., Cheever A. W. and Wynn T. A. (1998): IFN-gamma, IL-12 and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12. J Immunol, 161: 4201-10.
48. Hoffmann K. F., Cheever A. W. and Wynn T. A. (2000): IL-10 and the dangers of immune polarization, excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol, 164: 6406-16.
49. Hosseinimehr S. J. and Nemati A. (2006): Radioprotective effects of hesperidin against gamma irradiation in mouse bone marrow cells. Br J Radiol, 79(941): 415-8.
50. Huang H. Q., Li S. C., Qin Z. H., Cao S. L., Yao Y., Liu Y. S., Li H. Y., Cai M. S., Li Z. J. and Shi Y. E. (2005): Synthesis and bioactivities of two multiple antigen peptides as potential vaccine against Schistosoma. Bioorganic Med Chem Lett, 15: 2415-19.
51. Iacomini J., Ricklan D. E. and Stadecker M. J. (1995): T cells expressing the gamma delta T cell receptor are not required for egg granuloma formation in schistosomiasis. Eur J Immunol, 25: 884-8.
52. Jankovic D., Wynn T. A., Kullberg M. C., Hieny S., Caspar P., James S., Cheever A. W. and Sher A. (1999): Optimal vaccination against Schistosoma mansonirequires the induction of both B cells and IFN gamma-dependent effector mechanisms. J Immunol, 162: 345-51.
53. Joseph A. L. and Boros D. L. (1993):Tumor necrosis factor plays a role in Schistosoma mansoni egginduced granulomatous inflammation, 151(10): 5461-71.
54. Jovanovic S. V., Steenken S., Tosic M., Marjonovic B. and Simic M. G. (1994): Flavonoids as antioxidants. J Am Chem Soci, 116: 4846-51.
55. Kabatereine N. B., Kemijumbi J., Ouma J. H., Sturrock R. F., Butterworth A. E., Madsen H., Ornbierg N., Dunne D. W. and Vennervald B. J. (2003): Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. Trans Roy Soc Trop Med Hyg, 97: 599-603.
56. Kamaraj S., Anandakumar P., Jagan S., Ramakrishnan G. and Devaki T. (2010): Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9. Euro J Pharmacol, 15: 320-7.
57. Kawaguchi K., Mizuno T., Aida K. and Uchino K. (1997): Hesperidin as an inhibitor of lipases from porcine pancreas and Pseudomonas. Biosci Biotech Bioch, 61: 102-4.
58. Kayser O., Kiderlen A. F. and Croft S. L. (2003): Natural products as antiparasitic drugs. Parasitol Res, 90: S55-62.
59. Keiser J., Chollet J., Xiao S. H., Mei J. Y., Jiao P. Y., Utzinger J. and Tanner M. (2009): Mefloquinean aminoalcohol with promising antischistosomal properties in mice. PLoS Negl Trop Dis, 3(1): e350.
60. Khalife J., Dunne D. W., Richardson B. A., Mazza G., Thorne K., Capron A. and Butterworth A. (1989): Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J Immunol, 142 (12):4422-7.
61. Khalil R. M., Hultner L., Mailhammer R., Luz A., Moeller J., Mohamed A. A., Omran S. and Dormer P. (1996): Kinetics of interleukin-6 production after experimental infection of mice with Schistosoma mansoni. Immunol, 89: 256-61.
62. Kim C. J. and Cho S. K. (1991): Pharmacological activities of flavonoids (II)-Structure activity relationships of flavonoids in immunosuppression. Arch Pharmacol Res, 14: 147-59.
63. Kim D. H., Song M. J., Bae E. A. and Han M. J. (2000): Inhibitory effect of herbal medicines on rotavirus infectivity. Biol Pharm Bull, 23: 356-8.
64. King C. H., Dickman K. and Tisch D. J. (2005): Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. The Lancet, 365(9470):1561-9.
65. Kloetzel K. (1967): A suggestion for the prevention of severe clinical forms of schistosomiasis mansoni. Bull World Health Organ, 37: 686-7.
66. Krolicki Z. and Lamer-Zarawaska E. (1984): Investigation of antifungal effect of flavonoids. Part 1. Herba Pol, 30: 53-7.
67. La Flamme A. C., Patton E. A., Bauman B. and Pearce E. J. (2001): IL-4 plays a crucial role in regulating oxidative damage in liver during Schistosomiasis. J. Immunol, 166: 1903-11.
68. Lahlou M. (2004): Study of the molluscicidal activity of some phenolic compounds: structure-activity relationship. Pharma Biol, 42: 258-61.
69. Lancelot J., Caby S., Dubois-Abdesselem F., Vanderstraete M., Trolet J., Oliveira G., Bracher F., Jung M. and Pierce R. J. (2013): Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets. PLoS Negl Trop Dis, 7(9): e2428.
70. Lee J. H., Kim Y. S., Lee H. K. and Han S. S. (1999): Antiviral activity of some flavonoids on herpessimplex viruses. Korean Pharmacog, 30: 34-9.
71. Leptak C. L. and McKerrow J. H. (1997)Schistosome egg granulomas and hepatic expression of TNFalpha are dependent on immune priming during parasite maturation. J Immunol, 158(1): 301-7.
72. Mantawy M. M., Ali H. F. and Rizk M. Z. (2011): Therapeutic effects of Allium sativum and Allium cepa in Schistosoma mansoni experimental infection. Rev Inst Med Trop, 53(3): 155-63.
73. McManus D. and Dalton J. (2006): Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica. Parasitol, 133: S43-61.
74. Molgaard P., Nielsen S. B., Rasmussen D. E., Drummond R.B., Makaza N. and Andreassen J. (2001): Anthelminthic screening of Zimbabwean plants traditionally used against schistosomiasis. J Ethnopharmacol, 74: 257-64.
75. Mountford A. P. and Pearlman E. (1998):Interleukin-12 and the host response to parasitic helminths; the paradoxical effect on protective immunity and immunopathology. Parasit Immunol, 20: 509-17.
76. Olszanecki R., Gebska A., Kozlovski V. I. and Gryglewski R. J. (2002): Flavonoids and nitric oxide synthase. J Physiol Pharmacol, 53: 571-84.
77. Panasiak W., Wleklik M., Oraczewska A. and Luczak M. (1989): Influence of flavonoids on combined experimental infections with EMC virus and Staphylococcus aureus in mice. Acta Microbiol Pol, 38(2):185-8.
78. Parreira N. A., Magalhães L. G., Morais D. R., Caixeta S. C., de Sousa J. P., Bastos J. K., Cunha W. R., Silva M. L., Nanayakkara N. P., Rodrigues V. and da Silva Filho A. A. (2010): Antiprotozoal, schistosomicidal, and antimicrobial activities of the essential oil from the leaves of Baccharis dracunculifolia. Chem Biodiv, 7: 993-1001.
79. Pearce E. J., Caspar P., Gryzch J. M., Lewis F. A. and Sherm A. (1991):Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a helminth, Schistosoma mansoni. J Exp Med, 173(1): 159-66.
80. Pellegrino J., Oliveira C. A., Faria J. and Cunha A. (1962): New approach to the screening of drugs in experimental Schistosoma mansoni in mice. Am J Trop Med Hyg, 11: 201-15.
81. Pellegrino J., Lima-Costa F. F., Carlos M. L. and Mello R. T. (1977): Experimental chemotherapy of schistosomiasis mansoni. Parasitol Res, 52(2): 151-68.
82. Pica-Mattoccia L. and Cioli D. (2004): Sex-and stagerelated sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int J Parasitol, 34: 527-33.
83. Piper K. P., Mott R. F. and McLaren D. J. (1990): Schistosoma mansoni: Histological analysis of the synergetic interaction between vaccine immunity and praziquantel therapy in the lungs of mice. Parasite Immunol, 12(4): 367-87.
84. Portela J., Boissier J., Gourbal B., Pradines V., Collière V., Coslédan F., Meunier B. and Robert A. (2012): Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni. PLoS Negl Trop Dis, 6(2): e1474.
85. Pyrrho A. S., Ramos J. A., Neto R. M., Silva C. S., Lenzi H. L., Takiya C. M. and Gattass C. R. (2002): Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity. Antimicrob Agents Chemother, 46: 3490-8.
86. Rakasz E., Blum A. M., Metwali A., Elliott D. E., Li J., Ballas Z. K., Qadir K., Lynch R., and Weinstock J. V. (1998): Localization and regulation of IFN-gamma production within the granulomas of murine schistosomiasis in IL-4-deficient and control mice. J. Immunol, 160:4994-9.
87. Rezende S. A., Silva-Teixeira D. N., Drummond S. C. and Goes A. M. (1997): IL-10 plays a role in the modulation of human granulomatous hypersensitivity against Schistosoma mansoni eggs induced by immune complexes. Scand J Immunol, 46: 96-102.
88. Sanderson L., Bartlett A. and Whitfield P. J. (2002): In vitro and in vivostudies on the bioactivity of a ginger (Zingiber officinale) extract towards adult schistosomes and their egg production. J Helminthol, 76: 241-7.
89. Savioli L., Albonico M., Engels D. and Montresor A. (2004): Progress in the prevention and control of schistosomiasis and soil-transmitted helminthiasis. Parasitol Int, 53: 103-13.
90. Secor W. E. (2012): The effects of schistosomiasis on HIV/AIDS infection, progression and transmission. Curr Opin HIV AIDS, 7(3): 254-9.
91. Shaw M. K. (1990): Schistosoma mansoni: stagedependent damage after in vivo treatment with praziquantel. Parasitol, 100: 65-72.
92. Sher A., Fiorentino D., Caspar P., Pearce E. and Mosmann T. (1991): Production of IL-10 by CD4-T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J Immunol, 147: 2713-6
93. Silva C. L., Lenzi H. L., Silva V. F., Paulo F. O. and Noël F. (2003): Cellular mechanisms involved in the increased contraction of portal veins from Schistosoma mansoni-infected mice. Parasitol Res, 89(1): 16-22.
94. Smithers S. R. and Terry R. J. (1965): The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitol, 55(4): 695-700.
95. Stirewalt M. A. and Dorsey C. H. (1974): Schistosoma mansoni: cercarial penetration of host epidermis at the ultrastructural level. Exp Parasit, 35: 1-15.
96. Tendler M., Pinto R. M., Oliveira Lima A., Gebara G. and Katz N. (1986): Schistosoma mansoni vaccination with adult worm antigens. Int J Parasitol, 16:347-52.
97. Tian Q., Miller E. G., Ahmad H., Tang L. and Patil B.S. (2001): Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer, 40: 180-4.
98. Torben W., Ahmad G., Zhang W. and Siddiqui A. A. (2011): Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models. Vaccine, 29: 2262-71.
99. Utzinger J., Keiser J., Shuhua X., Tanner M. and Singer B. H. (2003): Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother, 47:1487-95.
100. van der Werf M.J., de Vlas S. J., Brooker S., Looman C. W., Nagelkerke N. J., Habbema J. D. and Engels D. (2003): Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop, 86: 125-39.
101. Vella A. T. and Pearce E. J. (1992): CD4 Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-likestage. J Immunol, 148: 2283-90.
102. Versantvoort C. H., Schuurhuis G. J., Pinedo H. M., Eekman C. A., Kuiper C. M., Lankelma J. and Broxterman H. J. (1993):Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br J Cancer, 68(5): 939-46.
103. Von Lichtenberg F. (1962):Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse. Am J Pathol, 41:711-31.
104. Wacker A. and Eilmes H. G. (1975): Virus inhibition using hesperidin Naturwissenschaften, 62: 301.
105. WHO (2012):Accelerating work to overcome the global impact of neglected tropical disease:a roadmap for implementation. (http://www. who.int/neglected_diseases/NTD_RoadMap_2012_ Fullversion.pdf).
106. Winawer S., Fletcher R., Rex D., Bond J., Burt R., Ferrucci J., Ganiats T., Levin T., Woolf S., Johnson D., Kirk L., Litin S. and Simmang C. (2003): Colorectal cancer screening and surveillance: clinical guidelines and rationaleupdate based on new evidence. Gastroenterol, 124: 544-60.
107. Wynn T. A., Cheever A. W., Jankovic D., Poindexter R. W., Caspar P., Lewis F. A. and Sher A. (1995): An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature, 376: 594-6.
108. Wynn T. A., Reynolds A., James S. L., Cheever A.W., Caspar P., Hieny S., Jankovic D., Strand M. and Sher A. (1996): IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol, 157: 4068-78.
109. Wynn T. A., Cheever A. W., Williams M. E., Hieny S., Caspar P., Kuhn R., Muller W. and Sher A. (1998). IL-10 regulates liver pathology in acute murine schistosomiasis mansonibut is not required for immune down-modulation of chronic disease. J. Immunol, 160: 4473-80.
110. Ying L., ZhiSheng W. and AnGuo Z. (2009):Effects of hesperidin and chlorogenic acid on performance, antioxidance and immunity of weaned piglets. Chin J Veter Sci, 29: 1233-6.
111. Yu L., Sun X., Yang F., Yang J., Shen J. and Wu Z. (2012):Inflammatory cytokines IFN-γ, IL-4, IL-13 and TNF-α alterations in schistosomiasis: a metaanalysis. Parasitol Res, 110: 1547-52.
112. Zhang C., Lu Y., Tao L., Tao X., Su X. and Wei D. (2007):Tyrosinase inhibitory effects and inhibition mechanisms of nobiletin and hesperidin from citrus peel crude extracts. J Enzym Inhib Medic Chemi, 22:91-8.